BioStone AsurDx™ iELISA for African Swine Fever Evaluated by FLI ASF Reference Laboratory and Published in Pathogens

News

Dallas – Forth Worth, TX — May 12, 2026  — BioStone Animal Health is pleased to announce that the AsurDx™ African Swine Fever Virus (ASFV) Antibody Indirect ELISA (iELISA) has been independently evaluated by the Friedrich-Loeffler-Institut (FLI), Germany’s National Reference Laboratory for African Swine Fever (ASF), with the study results published in the peer-reviewed scientific journal Pathogens. The…

BioStone AsurDx™ bELISA and iELISA for African Swine Fever have been evaluated by OIE ASF Reference Laboratory and published in Pathogens.

News

DALLAS-FORT WORTH, TX — November 12, 2024— BioStone Animal Health is pleased to announce that evaluation of our AsurDx™ bELISA and iELISA for African Swine Fever (ASF) antibody was published on November 8, 2024, in the peer-reviewed journal, Pathogens [1]. The evaluation was conducted at the National Center for Foreign Animal Disease (NCFAD, Winnipeg, Canada), which is one…